What if the clinic came to you?

Care closer to everyday life

A clinic can offer effective treatment and still be difficult to reach. In its 4 November 2026 update, the US National Institutes of Health highlights mobile teams bringing HIV prevention and addiction services into communities. Barriers such as unstable housing, stigma and disconnected services help explain why this approach matters.

What the trial tested

The HPTN 094 randomized trial, published in JAMA Psychiatry on 4 November 2026, included 409 adults in five US cities. Participants injected drugs, had opioid use disorder and did not have HIV. Both groups received peer navigation: help connecting with care. One group also received integrated services through mobile clinics for 26 weeks.

The headline needs context

At 52 weeks, researchers recorded four deaths among 203 mobile-care participants, compared with 13 among 206 in the comparison group. However, the trial did not find statistically significant improvements in its two primary outcomes: use of HIV-prevention medication, known as PrEP, and medication for opioid use disorder at 26 weeks.

What we still do not know

Deaths were a secondary outcome, with only 17 events in total. The survival finding needs replication. This was an open-label trial in a specific US population; it does not establish what would happen in Egypt or other settings. It also tested a package of services, so the results cannot tell us which component mattered most.

Between shifts

For FOMO readers, the interesting question is about service design: how can healthcare teams make care easier to reach and keep using? This study gives that conversation evidence to examine, while leaving important questions open.

Read the sources

Sources checked 5 November 2026. Original educational summary; not personal medical advice. No study photographs or illustrations have been reproduced.